Previous Article | Next Article ![]()
Journal of Virology, February 1999, p. 920-929, Vol. 73, No. 2
Ophthalmology Research Laboratories,
Cedars-Sinai Medical Center Burns & Allen Research Institute, Los
Angeles, California 90048,1 and
Department of Ophthalmology, UCLA School of Medicine, Los
Angeles, California 900242
Received 18 September 1998/Accepted 22 October 1998
The herpes simplex virus type 1 (HSV-1) latency-associated
transcript (LAT) gene is essential for efficient spontaneous
reactivation of HSV-1 from latency. We previously reported that
insertion of the LAT promoter and just the first 1.5 kb of the 8.3-kb
LAT gene into an ectopic location in the virus restored wild-type
spontaneous reactivation to a LAT null mutant. This mutant, LAT3.3A
(previously designated LAT1.5a), thus showed that the expression of
just the first 1.5 kb of LAT is sufficient for wild-type spontaneous
reactivation. We also showed that in the context of the entire LAT
gene, deletion of LAT nucleotides 76 to 447 (LAT mutant
dLAT371) had no effect on spontaneous reactivation or
virulence. We report here on a LAT mutant designated LAT2.9A. This
mutant is similar to LAT3.3A, except that the ectopic LAT insert
contains the same 371-nucleotide deletion found in dLAT371.
We found that LAT2.9A had a significantly reduced rate of spontaneous
reactivation compared to marker-rescued and wild-type viruses. This was
unexpected, since the combined results of dLAT371 and
LAT3.3A predicted that spontaneous reactivation of LAT2.9A would be
wild type. We also found that LAT2.9A was more virulent than wild-type
or marker-rescued viruses after ocular infection of rabbits. This was
unexpected, since LAT null mutants and LAT3.3A have wild-type
virulence. These results suggest for the first time (i) that regions
past the first 1.5 kb of LAT can compensate for deletions in the first
1.5kb of LAT and may therefore play a role in LAT dependent spontaneous
reactivation and (ii) that regions of LAT affect viral virulence.
After ocular herpes simplex virus
type 1 (HSV-1) ocular infection, the virus travels up nerves
to the trigeminal ganglia (TG), where it establishes a latent
infection. Latency lasts for the life of the infected individual. HSV-1
can reactivate from latency and travel back to the eye, where it can be
detected in tears and cause recurrent corneal disease. Recurrent ocular
HSV-1 can lead to scarring of the cornea and loss of sight. In
developed nations, HSV-1 is the most common cause of corneal blindness
due to an infectious agent (12). How HSV-1 establishes,
maintains, and reactivates from latency remains unknown.
The latency-associated transcript (LAT) is the only viral gene that is
abundantly transcribed during latency (20). LAT is located
in the long repeat region of the viral genome and thus is present in
two copies per genome. LAT is initially transcribed as an 8.3-kb RNA
(4, 26). This primary LAT transcript gives rise to a family
of LAT RNAs, including the very stable 2-kb LAT (20, 24,
25), which appears to be an intron produced by splicing
(6). LAT transcription-negative mutants have been shown to
reactivate poorly by explant or induced reactivation in the mouse
(9, 10, 21), by induced reactivation in the rabbit (1,
23), and by spontaneous reactivation in the rabbit (14,
17). Thus, LAT is essential for efficient, wild-type reactivation
from sensory neurons.
The mechanism by which LAT functions remains unknown. No LAT-encoded
protein has been detected during latency and there does not appear to
be a LAT open reading frame that is well conserved among LAT genes
capable of sustaining spontaneous reactivation (5). Thus, in
the absence of undetected, atypical splicing, it is unlikely that
LAT's function is due to a LAT protein. LAT's function also does not
appear to be due to antisense downregulation of the important
immediate-early gene ICP0, which LAT overlaps in an antisense
direction. We recently showed that the first 1.5 kb of LAT alone is
sufficient for wild-type levels of spontaneous reactivation
(17). This region does not overlap any portion of any known
HSV-1 gene.
Mapping a LAT spontaneous reactivation function to the first 1.5 kb of
LAT was done by inserting the LAT promoter and the first 1.5 kb of LAT
into an ectopic location in the genome of a LAT null mutant between
HSV-1 genes UL37 and UL38 (17). This completely restored
wild-type levels of spontaneous reactivation. Another LAT mutant,
dLAT371, containing a StyI-StyI
deletion that removed LAT nucleotides 76 to 447 was also wild type for
spontaneous reactivation (18). Thus, this 371-nucleotide
region within the first 1.5 kb of the primary LAT transcript did not
appear to be essential for efficient spontaneous reactivation.
We report here on a mutant that is a combination of LAT3.3A and
dLAT371. This virus, designated LAT2.9A, contains a LAT
insert at the same ectopic location as LAT3.3A. This insert is
identical to that in LAT3.3A (i.e., the LAT promoter and the first 1.5 kb of LAT), except that LAT nucleotides 76 to 447 are deleted. As with
LAT3.3A, the LAT promoter and the first 1.67 kb of LAT are deleted from
both copies of LAT in the long repeat and therefore the only LAT
produced originates from the ectopic insert. We predicted that LAT2.9A,
like LAT3.3A and dLAT371, would have wild-type spontaneous reactivation. Instead, LAT2.9A had a significantly reduced spontaneous reactivation rate that was comparable to that of the LAT null mutant
dLAT2903. LAT2.9A also was significantly more virulent than
wild-type virus. This was also unexpected, since dLAT2903, LAT3.3A, and dLAT371 all appeared to have wild-type virulence.
Cells and virus.
Rabbit skin (RS) cells were grown in Eagle
minimal essential media (MEM) supplemental with 5% fetal calf serum
(FCS). CV-1 cells were grown in MEM supplemented with 10% FCS. CV-1
cells were used for growth kinetic studies. RS cells were used for all other tissue culture procedures, including the preparation of virus
stocks. All mutants were derived from HSV-1 strain McKrae. The parental
McKrae virus and all mutants were triple plaque purified and passaged
only one or two times prior to use. The construction and properties of
dLAT2903, LAT3.3A (previously designated LAT1.5a), and
dLAT371 have been previously described (14, 17,
18).
Construction of LAT2.9A.
The parental virus for this
construct was dLAT2093, a mutant of HSV-1 strain McKrae
containing a 1.8-kb (EcoRV-HpaI) deletion in both
copies of LAT that removed 0.2 kb of the LAT promoter and 1.6 kb of the
5' end of the primary 8.3-kb LAT transcript (14). The
previously cloned EcoRI A fragment from HSV-1 strain McKrae
(15) was digested with BamHI, and the products
were separated by agarose gel electrophoresis. A resulting 7.5-kb band
containing the McKrae genomic region including UL37 and UL38 was
isolated by electroelution and cloned into the BamHI site of
plasmid pEV-vrf3 (3, 15) to produce the plasmid pV375. pV375
was digested with AflII, the overhang was filled in using
the Klenow fragment, and the blunt ends were self-ligated to create a
unique PacI site in the plasmid between the sequences for
UL37 and UL38. The resulting plasmid, designated pV375Pac, was
amplified by transformation into Escherichia coli
RR1
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
A Herpes Simplex Virus Type 1 Latency-Associated
Transcript Mutant with Increased Virulence and Reduced
Spontaneous Reactivation
![]()
ABSTRACT
Top
Abstract
Introduction
Materials and methods
Results
Discussion
References
![]()
INTRODUCTION
Top
Abstract
Introduction
Materials and methods
Results
Discussion
References
![]()
MATERIALS AND METHODS
Top
Abstract
Introduction
Materials and methods
Results
Discussion
References
CI857 according to standard protocol. An
HpaI-HpaI restriction fragment consisting of 1.8 kb of the LAT promoter and the first 1.5 kb of the LAT RNA
(17) was cloned into the PacI site of pNEB193 and
further digested with StyI to remove a 371-nucleotide
StyI-StyI region corresponding to LAT nucleotides
76 to 447. The plasmid was then self-ligated and digested with
PacI, and the resulting 2.9-kb band was cloned into the
PacI site of pV375Pac to produce pV375LAT2.9.
Replication of virus in tissue culture.
CV-1 cell monolayers
at approximately 70 to 80% confluency were infected with virus at 0.01 PFU/cell, and all monolayers were refed with exactly the same amount of
MEM containing 10% FCS. Virus was harvested for titration at various
times by two cycles of freeze-thawing the monolayers plus media
(
80°C to room temperature). The PFU/milliliter values were
determined by standard plaque assays on RS cells.
Rabbits. Eight- to ten-week old New Zealand White female rabbits (Irish Farms) were used for all experiments. Rabbits were treated in accordance with ARVO (Association for Research in Vision and Ophthalmology), AALAC (American Association for Laboratory Animal Care), and NIH (National Institutes of Health) guidelines.
Rabbit model of ocular HSV-infection, latency, and spontaneous reactivation. Rabbits were bilaterally infected without scarification or anesthesia by placing 2 × 105 PFU of HSV-1 per eye into the conjunctival cul-de-sac, closing the eye, and rubbing the lid gently against the eye for 30 s (20). At this dose of HSV-1 McKrae virtually all of the surviving rabbits harbor a bilateral latent HSV infection in both trigeminal ganglia, resulting in a high group rate of spontaneous reactivation with the McKrae strain of HSV-1. Latency is assumed to have been established by 28 days postinfection. Acute ocular infection of all eyes was confirmed by HSV-1 positive tear film cultures collected on days 3 and 4 postinfection.
Detection of spontaneous reactivation by ocular shedding. Beginning on day 31 postinfection, tear film specimens were collected daily from each eye for 26 days as previously described (22), using a nylon-tipped swab. The swab was then placed in 0.5 ml of tissue culture medium and squeezed, and the inoculated medium was used to infect primary rabbit kidney cell monolayers. These cell monolayers were observed in a masked fashion by phase light microscopy for up to 30 days to monitor HSV-1 cytopathic effects (CPE). All positive monolayers were blind passaged onto fresh cells to confirm the presence of virus. DNA was purified from randomly selected positive cultures derived from latently infected rabbits and analyzed by restriction enzyme digestion and Southern blots to confirm that the CPE was due to reactivated HSV-1 and that the reactivated virus was identical to the input virus.
Virus replication in rabbit eyes. Tear films were collected as described above on various days postinfection. The amount of virus in each tear film was determined by standard plaque assays on RS cells.
RT-PCR. Reverse transcriptase (RT)-PCR was done as we previously described (17) with minor modifications. Briefly, RNA was isolated with Trizol (Gibco-BRL, Grand Island, N.Y.) from individual TG from latently infected rabbits or from infected CV-1 cell monolayers and treated with DNase I (12 U, 37°C, 30 min; Stratagene, La Jolla, Calif.). RNA was isolated with an RNeasy Mini-Kit (Quiagen, Santa Clarita, Calif.). The purified RNAs were subjected to first-strand cDNA synthesis by Superscript II (Gibco-BRL) according to the manufacturer's protocol. The primer for first-strand cDNA synthesis from the LAT RNA was 5'-CTTTGTTGAACGACACCGGGGCGCCCTCGA-3'. The cDNA product was then amplified by PCR with the primer 5'-CCACAACGGCCCGGCGCATGCGCTGTGGTT-3' and the first-strand primer. These primers generate a 160-bp product specific for LAT nucleotides 471 to 631. The amplified products were fractionated by gel electrophoresis, transferred to a nylon membrane, and hybridized to the 32P-labeled internal probe 5'-TCTCCCCCCCCCCTTCTTCACCCCCAGTAC-3' corresponding to LAT nucleotides 550 to 580.
Statistical analysis. Statistical analyses were performed by using Instat, a personal computer software program. For analyses with either the Student t test, the Mann-Whitney rank sum test, the chi-square test, or the Fisher exact test the results were considered statistically significant when the P value was <0.05.
| |
RESULTS |
|---|
|
|
|---|
Structure of LAT2.9A.
The genomic structures of wild-type
HSV-1 McKrae, LAT2.9A, and the other viruses used in this study are
shown in Fig. 1A. All
of the viruses were derived from HSV-1 strain McKrae. The construction
and properties of dLAT2903 and its marker-rescued virus
dLAT2903R, dLAT371 and its marker-rescued virus
dLAT371R, and LAT3.3A (previously designated LAT1.5a) have
been described previously (14, 17, 18). The LAT
transcript(s) made by each virus are detailed in Fig. 1B. Wild-type
McKrae and the marker-rescued viruses dLAT2903R and
dLAT371R contain two copies of LAT, one in each viral long
repeat (Fig. 1A, top). The viral long repeats are expanded (in dashed
lines) to show the relative location and status of the LAT gene. In the
topmost panel, the location of the ICP0 and ICP34.5 genes are shown for
reference. The primary LAT transcript in the wild-type and the
marker-rescued viruses is approximately 8.3 kb (Fig. 1A, top panel, and
Fig. 1B) (24, 25). A very stable and easily detected 2-kb
LAT (solid rectangle) appears to be an intron derived by splicing of
the primary LAT (6). dLAT2903 contains a deletion
in both copies of LAT from
161 to +1,667 relative to the start of the
primary LAT transcript (Fig. 1A, indicated by "XXXXX"). This virus
is missing key promoter elements, makes no LAT RNA (Fig. 1B), and is a
true LAT null mutant. dLAT371 contains a 371-nucleotide
deletion of LAT nucleotides 76 to 447, corresponding to a
StyI-StyI region prior to the 2-kb LAT (Fig. 1A,
third panel, indicated by "X"). This virus makes a normal primary
LAT transcript except that it is missing LAT nucleotides 76 to 447 (Fig. 1B). LAT3.3A is derived from dLAT2903 by insertion of
1.8 kb of the LAT promoter and the first 1.5 kb of LAT into a unique
PacI site that was constructed between UL37 and UL38 (Fig.
1A). LAT3.3A and LAT2.9AR make no LAT RNA from either copy of LAT in
the long repeats, but they do make a 1.5-kb LAT RNA from the ectopic
insert that corresponds to the first 1.5 kb of the primary LAT (Fig.
1B). LAT2.9A is identical to LAT3.3A, except that LAT nucleotides 76 to
447 have been deleted from the inserted 1.5-kb LAT region (Fig. 1A).
LAT2.9A therefore transcribes an RNA of 1,128 nucleotides corresponding
to LAT nucleotides 1 to 76 and 447 to 1,499. The construction of all
the above mutants except LAT2.9A and LAT2.9AR have been previously
described (14, 17, 18). Additional details of the
construction of LAT2.9A and LAT2.9AR are given in Materials and
Methods.
|
Southern analysis of the structure of LAT2.9A. Southern analyses of viral DNAs were performed to confirm the structure of LAT2.9A (Fig. 2). DNAs were individually digested with PacI and probed with a 32P-labeled restriction fragment (StyI-HpaI; LAT nucleotides 447 to 1,499) that is completely within the LAT region deleted in dLAT2903 and that therefore can hybridize only with LAT sequences in the LAT2.9A insert (Fig. 2A). The wild-type virus (lane 1) produced a single large band of genome size as expected, since PacI does not cut wild-type HSV-1. The dLAT2903 DNA produced no band (lane 2), since the sequences corresponding to the probe are deleted from this virus. PacI should cut the PacI sites flanking the 2.9-kb LAT fragment inserted between UL37 and UL38 in LAT2.9A to produce a single band of 2.9 kb that hybridizes to the probe as is seen in lane 3. Similarly, PacI cuts the correspondingPacI sites in LAT2.9AR and LAT3.3A, producing bands of 3.3 kb (lanes 4 and 5). These results indicate that LAT2.9A contains the expected 2.9-kb LAT insert between UL37 and UL38 and that the corresponding region in LAT2.9AR has been rescued back to the wild-type size (lane 4) seen in LAT3.3A (lane 5).
|
|
In vivo replication of LAT2.9A. Rabbits were infected with 2 × 105 PFU of LAT2.9A, dLAT2903, dLAT2903R, or LAT3.3A per eye. Tears were collected at the indicated times (Fig. 3B), and the virus yield was determined by plaque assay. As we have previously shown (14, 17), replication of dLAT2903 and LAT3.3A in rabbit eyes was similar to that of wild type (dLAT2903R) virus. Replication of LAT2.9A (Fig. 3B, open circles) appeared to be slightly lower than that of LAT3.3A and dLAT2903R (solid circles and squares) on days 3 and 5 but not on day 7. However, as indicated by the overlapping error bars, these minor differences were not significant.
Reduced survival of rabbits ocularly infected with LAT2.9A.
Eighteen rabbits per group were infected with 2 × 105
PFU of LAT2.9A, dLAT2903, dLAT2903R, or LAT3.3A
per eye. Only 17% of the LAT2.9A-infected rabbits survived for 21 days
(Table 1, experiment 1, column 3) compared to 33-39% survival for the
other groups. Since dLAT2903, dLAT2903R, and
LAT3.3A all have wild type parental McKrae virulence in rabbits
(14, 17), it appeared that survival of LAT2.9A may have been
reduced compared to wild type. However, the differences were not
significant (Table 1, experiment 1, column 4). To determine if the tendency in experiment 1 for LAT2.9A to
be more virulent than wild type was meaningful, additional experiments
were done. In a second experiment, 22 rabbits per group were infected
with LAT2.9A or dLAT2903R (Table 1, experiment 2). Again,
the percentage of rabbits surviving infection with LAT2.9A appeared to
be reduced compared to wild type (32 versus 55%). However, as in
experiment 1, the differences was not statistically significant (Table
1, column 3).
|
Reduced spontaneous reactivation of LAT2.9A. Beginning at 31 days postinfection (at which time latency had already been established), all eyes from the surviving rabbits in experiments 1, 2, and 3 were swabbed once a day for 26 days to collect tear films for analysis of reactivated virus as described in Materials and Methods. In experiment 1, LAT2.9A was compared to dLAT2903, which has reduced spontaneous reactivation, and to LAT3.3A and dLAT2903R, both of which have spontaneous reactivation rates identical to wild-type McKrae. The cumulative number of virus-positive tear film cultures is shown in Fig. 4A. Because of the different numbers of surviving rabbits in the different groups, the data were standardized to represent cumulative positive cultures per eye. The cumulative spontaneous reactivation rate in rabbits latently infected with LAT2.9A (Fig. 4A, open circles; approximately 1.8/eye on day 26) appeared to be less than dLAT2903R and LAT3.3A (Fig. 4A, solid squares and circles; approximately 3 to 3.5/eye) and slightly greater than dLAT2903 (Fig. 4A, open squares; approximately 1/eye).
|
|
Transcription of LAT in tissue culture and the TG of rabbits latently infected with LAT2.9A. To confirm that transcription of LAT in LAT2.9A was as expected, RT-PCR analyses were done. CV-1 cells were infected at a multiplicity of infection of 2, and RT-PCR was performed on total RNA. The primers used generate a 160-bp product specific for LAT nucleotides 471 to 631. The RT-PCR products were subjected to Southern analysis by using an internal 32P-labeled probe (LAT nucleotides 550 to 580) (Fig. 5A). As expected, a 160-bp RT-PCR product was detected in cells infected with dLAT371, LAT3.3A, or LAT2.9A (Fig. 5A). In addition, the apparent intensity of the RT-PCR bands in each lane was similar. Since we previously showed that the amount of LAT RNA in TG latently infected with dLAT371 or LAT3.3A is similar to that of wild-type McKrae (17, 18), these results suggest that in tissue culture the predicted LAT2.9A RNA was present in wild-type amounts. No RT-PCR product was produced from dLAT2903-infected cells, confirming that RNA corresponding to this region of LAT was not made by the dLAT2903 LAT null mutant.
|
| |
DISCUSSION |
|---|
|
|
|---|
In the experiments reported here, LAT2.9A had increased virulence (based on reduced rabbit survival) and decreased spontaneous reactivation. In contrast, its marker-rescued virus, LAT2.9AR, was wild type for both phenotypes. This very strongly suggests that the increased virulence and the decreased spontaneous reactivation of LAT2.9A were both due to the 371-nucleotide StyI-StyI deletion. Both of these phenotypes were unexpected.
In contrast to the StyI-StyI deletion in LAT2.9A, we previously showed that deletion of the StyI-StyI region in the context of the entire LAT gene (dLAT371) (18) did not effect spontaneous reactivation. In addition, we previously showed that insertion of the LAT promoter and the first 1.5 kb of LAT (LAT 3.3A) into an ectopic location in the LAT null mutant dLAT2903 restored wild-type spontaneous reactivation (17). LAT2.9A is identical to LAT3.3A except that it contains the StyI-StyI deletion. Thus, it was expected that LAT2.9A would have a wild-type rate of spontaneous reactivation.
Possible explanations for the reduced reactivation of LAT2.9A fall into at least three categories. (i) The first is the LAT copy number. It is possible that the StyI-StyI region is not essential for wild-type spontaneous reactivation when two copies of LAT are present in the genome. (ii) The second is the LAT location. It is possible that when LAT is located in its normal location in the long repeats, the StyI-StyI region is not required, but the StyI-StyI region is required for LAT function when LAT is not in its normal location. (iii) The third is the lack of LAT from 1.5 to 8.3 kb. The StyI-StyI region may not be required in the context of the otherwise-complete LAT gene, but it is needed when only the first 1.5 kb of LAT is present. This would suggest that there are one or more additional functional regions downstream of the first 1.5-kb region. Since both dLAT371 and LAT3.3A have wild-type rates of spontaneous reactivation, the region pre-1.5 kb and the region post-1.5 kb must each be able to produce wild-type levels of spontaneous reactivation, but the effects of this must not be additive. This would easily occur if each functional region resulted in the maximum spontaneous reactivation possible in the rabbit model. Although not easily detected in animal models, the presence of multiple independent functional regions within LAT may have beneficial effects in nature. It would also help explain why selective pressure has maintained the entire 8.3-kb LAT gene in all of the HSV-1 isolates examined, despite the fact that the first 1.5 kb of LAT alone is sufficient for maximum levels of spontaneous reactivation in the rabbit. Alternatively, functional regions after the first 1.5 kb of LAT may not be fully independently able to produce wild-type levels of spontaneous reactivation but may be able to compensate for the StyI-StyI deletion in the first 1.5 kb of LAT, perhaps via interactions with part of the remaining 1.5-kb region. It is also possible that a previously undetected splicing event occurs, either partially or completely within the StyI-StyI region, and that this splicing is required for LAT function in the context of the first 1.5 kb but that it can be compensated for by sequences downstream of the first 1.5 kb.
Although LAT may partially inhibit productive gene expression (2, 7, 11), there have been no previously reports of any LAT mutants with increased virulence. Over the course of numerous experiments in our laboratory, the virulence of the LAT null mutant, dLAT2903 (14), has always been similar to that of its wild-type parent. In addition, the virulence of LAT3.3A has been indistinguishable from that of both its direct parent, dLAT2903, and dLAT2903's wild-type McKrae parent (17). In contrast, LAT2.9A, which is effectively a deletion of the StyI-StyI region from LAT3.3A, had significantly increased virulence. Moreover, the increased virulence of LAT2.9A was restored to the less-virulent wild-type level by rescue of the StyI-StyI deletion in the ectopic insert (LAT2.9AR). Thus, the increased virulence of LAT2.9A appeared to be due to the 371-nucleotide StyI-StyI deletion in its ectopic LAT insert.
Why does the deletion of LAT nucleotides 76 to 447 in LAT2.9A increase
virulence when the deletion of LAT nucleotides
161 to +1667
(dLAT2903) does not? Asked another way, why does the insertion of LAT nucleotides
1800 to +76 plus 447 to 1667 between UL37 and UL38 in dLAT2903 increase virulence, whereas the
insertion of LAT nucleotides
1800 to +1667 does not? or, from yet
another perspective, why does preventing transcription of LAT
nucleotides 76 to 447 along with LAT nucleotides 1667 to 8323 increase
virulence, whereas preventing all LAT transcription does not alter
virulence? This phenomenon, in which a small deletion has a larger
effect than a larger deletion that encompasses the smaller deletion, is
reminiscent of results often seen when mapping promoter activity. This
is because promoters often contain numerous functional elements, some
of which work in concert and some of which act antagonistically. A
series of deletions that removes successively larger regions of the 5'
end of a promoter often produces a pattern of promoter activity that
increases and decreases several times before all activity is gone.
Since it is unlikely that LAT encodes a protein and since deletion of
the StyI-StyI region does not appear to alter the
expression of LAT itself, this parallel suggests that the LAT RNA may
regulate the expression or function of one or more viral and/or
cellular genes. This regulation could be direct or through the
intervention of other gene products. In either situation, LAT could
enhance spontaneous reactivation by being a key factor involved in
intricate, controlled regulation of viral and/or cellular genes
involved in the latency-reactivation cycle.
We previously reported that d34.5, a McKrae-based mutant
deleted for both copies of
34.5, the gene for ICP34.5 (one in each long repeat), had dramatically decreased virulence and poor spontaneous reactivation after infection of rabbits with 2 × 105
PFU/eye (19). However, after an extremely high-dose ocular infection with over 108 PFU/eye, d34.5 was still
avirulent but its spontaneous reactivation rate was wild type
(16). A second mutant, derived from d34.5 and
designated d34.5A, contains one copy of
34.5 inserted
into the same ectopic location used for LAT2.9A. d34.5A, has
wild-type spontaneous reactivation while remaining much less virulent
than wild type (13). These previous studies showed that
decreased virulence does not necessarily result in decreased
spontaneous reactivation. The results reported here extend and
complement the above findings by showing that increased virulence does
not necessarily result in increased spontaneous reactivation. In 2.9A, increased virulence did not result in increased spontaneous
reactivation and, in fact, was coincident with decreased spontaneous
reactivation. These results confirm that the phenotypes for spontaneous
reactivation and virulence are separable.
Nonetheless, since LAT2.9A shows that LAT affects virulence as well as reactivation, is of interest to consider the possibility that in this mutant the increased virulence and the decreased spontaneous reactivation were related. It is possible that the increased virulence resulted in the elimination of neurons that would otherwise have become latently infected. This might result in fewer surviving latently infected neurons, resulting in a smaller pool of latently infected neurons capable of reactivation. This, in turn, would be expected to result in reduced spontaneous reactivation. Thus, one possible hypothesis that could be derived from these studies is that the normal function of LAT is to protect acutely infected neurons from death, thereby producing a larger pool of latently infected neurons. This larger pool of latently infected neurons would subsequently allow for increased spontaneous reactivation. Consistent with this, it has been proposed that the bovine herpes virus LR-RNA (latency-related RNA, comparable to LAT) encodes products that promote neuronal survival (8, 22). Unfortunately, in the rabbit model it has not yet been possible to detect decreased amounts of latent viral DNA or decreased numbers of latent viral DNA-positive neurons in the TG (13), and so this hypothesis remains to be tested.
| |
ACKNOWLEDGMENTS |
|---|
This work was supported by Public Health Service grants EY07566 and EY10243, the Discovery Fund for Eye Research, and the Skirball Program in Molecular Ophthalmology.
We thank Anita Avery for her expert technical support.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Ophthalmology Research Laboratories, Cedars-Sinai Medical Center Burns & Allen Research Institute, Davis Bldg., Rm. 5072, 8700 Beverly Blvd., Los Angeles, CA 90048. Phone: (310) 855-6457. Fax: (310) 652-8411. E-mail: Wechsler{at}CSMC.edu.
| |
REFERENCES |
|---|
|
|
|---|
| 1. |
Bloom, D. C.,
G. B. Devi-Rao,
J. M. Hill,
J. G. Stevens, and E. K. Wagner.
1994.
Molecular analysis of herpes simplex virus type 1 during epinephrine-induced reactivation of latently infected rabbits in vivo.
J. Virol.
68:1283-1292 |
| 2. | Chen, S. H., M. F. Kramer, P. A. Schaffer, and D. M. Coen. 1997. A viral function represses accumulation of transcripts from productive-cycle genes in mouse ganglia latently infected with herpes simplex virus. J. Virol. 71:5878-5884[Abstract]. |
| 3. | Crowl, R., C. Seamans, P. Lomedico, and S. McAndrew. 1985. Versatile expression vectors for high-level synthesis of cloned gene products in Escherichia coli. Gene 38:31-38[Medline]. (Erratum, 45:117, 1986.) |
| 4. |
Dobson, A. T.,
F. Sederati,
G. Devi-Rao,
W. M. Flanagan,
M. J. Farrell,
J. G. Stevens,
E. K. Wagner, and L. T. Feldman.
1989.
Identification of the latency-associated transcript promote by expression of rabbit beta-globin mRNA in mouse sensory nerve ganglia latently infected with a recombinant herpes simplex virus.
J. Virol.
63:3844-3851 |
| 5. | Drolet, B. S., G. C. Perng, J. Cohen, S. M. Slanina, A. Yukht, A. B. Nesburn, and S. L. Wechsler. 1998. The region of the herpes simplex virus type 1 LAT gene involved in spontaneous reactivation does not encode a functional protein. Virology 242:221-232[Medline]. |
| 6. |
Farrell, M. J.,
A. T. Dobson, and L. T. Feldman.
1991.
Herpes simplex virus latency-associated transcript is a stable intron.
Proc. Natl. Acad. Sci. USA
88:790-794 |
| 7. | Garber, D. A., P. A. Schaffer, and D. M. Knipe. 1997. A LAT-associated function reduces productive-cycle gene expression during acute infection of murine sensory neurons with herpes simplex virus type 1. J. Virol. 71:5885-5893[Abstract]. |
| 8. |
Jiang, Y.,
A. Hossain,
M. T. Winkler,
T. Holt,
A. Doster, and C. Jones.
1998.
A protein encoded by the latency-related gene of bovine herpesvirus 1 is expressed in trigeminal ganglionic neurons of latently infected cattle and interacts with cyclin-dependent kinase 2 during productive infection.
J. Virol.
72:8133-8142 |
| 9. |
Leib, D. A.,
C. L. Bogard,
M. Kosz-Vnenchak,
K. A. Hicks,
D. M. Coen,
D. M. Knipe, and P. A. Schaffer.
1989.
A deletion mutant of the latency-associated transcript of herpes simplex virus type 1 reactivates from the latent state with reduced frequency.
J. Virol.
63:2893-2900 |
| 10. |
Leib, D. A.,
K. C. Nadeau,
S. A. Rundle, and P. A. Schaffer.
1991.
The promoter of the latency-associated transcripts of herpes simplex virus type 1 contains a functional cAMP-response element: role of the latency-associated transcripts and cAMP in reactivation of viral latency.
Proc. Natl. Acad. Sci. USA
88:48-52 |
| 11. |
Mador, N.,
D. Goldenberg,
O. Cohen,
A. Panet, and I. Steiner.
1998.
Herpes simplex virus type 1 latency-associated transcripts suppress viral replication and reduce immediate-early gene mRNA levels in a neuronal cell line.
J. Virol.
72:5067-5075 |
| 12. | Nesburn, A. B. (ed.). 1983. Report of the Corneal Disease Panel: vision research: a national plan 1983-1987, vol. II, part III. C. V. Mosby Co., St. Louis, Mo. |
| 13. | Perng, G. C., K. Chokephaibulkit, R. L. Thompson, N. M. Sawtell, S. M. Slanina, H. Ghiasi, A. B. Nesburn, and S. L. Wechsler. 1996. The region of the herpes simplex virus type 1 LAT gene that is colinear with the ICP34.5 gene is not involved in spontaneous reactivation. J. Virol. 70:282-291[Abstract]. |
| 14. |
Perng, G. C.,
E. C. Dunkel,
P. A. Geary,
S. M. Slanina,
H. Ghiasi,
R. Kaiwar,
A. B. Nesburn, and S. L. Wechsler.
1994.
The latency-associated transcript gene of herpes simplex virus type 1 (HSV-1) is required for efficient in vivo spontaneous reactivation of HSV-1 from latency.
J. Virol.
68:8045-8055 |
| 15. | Perng, G. C., H. Ghiasi, R. Kaiwar, A. B. Nesburn, and S. L. Wechsler. 1994. An improved method for cloning portions of the repeat regions of herpes simplex virus type 1. J. Virol. Methods 46:111-116[Medline]. |
| 16. | Perng, G. C., H. Ghiasi, S. M. Slanina, A. B. Nesburn, and S. L. Wechsler. 1996. High-dose ocular infection with a herpes simplex virus type 1 ICP34.5 deletion mutant produces no corneal disease or neurovirulence yet results in wild-type levels of spontaneous reactivation. J. Virol. 70:2883-2893[Abstract]. |
| 17. | Perng, G. C., H. Ghiasi, S. M. Slanina, A. B. Nesburn, and S. L. Wechsler. 1996. The spontaneous reactivation function of the herpes simplex virus type 1 LAT gene resides completely within the first 1.5 kilobases of the 8.3-kilobase primary transcript. J. Virol. 70:976-984[Abstract]. |
| 18. | Perng, G. C., S. M. Slanina, H. Ghiasi, A. B. Nesburn, and S. L. Wechsler. 1996. A 371-nucleotide region between the herpes simplex virus type 1 (HSV-1) LAT promoter and the 2-kilobase LAT is not essential for efficient spontaneous reactivation of latent HSV-1. J. Virol. 70:2014-2018[Abstract]. |
| 19. | Perng, G. C., R. L. Thompson, N. M. Sawtell, W. E. Taylor, S. M. Slanina, H. Ghiasi, R. Kaiwar, A. B. Nesburn, and S. L. Wechsler. 1995. An avirulent ICP34.5 deletion mutant of herpes simplex virus type 1 is capable of in vivo spontaneous reactivation. J. Virol. 69:3033-3041[Abstract]. |
| 20. |
Rock, D. L.,
A. B. Nesburn,
H. Ghiasi,
J. Ong,
T. L. Lewis,
J. R. Lokensgard, and S. L. Wechsler.
1987.
Detection of latency-related viral RNAs in trigeminal ganglia of rabbits latently infected with herpes simplex virus type 1.
J. Virol.
61:3820-3826 |
| 21. |
Sawtell, N. M., and R. L. Thompson.
1992.
Herpes simplex virus type 1 latency-associated transcription unit promotes anatomical site-dependent establishment and reactivation from latency.
J. Virol.
66:2157-2169 |
| 22. | Schang, L. M., A. Hossain, and C. Jones. 1996. The latency-related gene of bovine herpesvirus 1 encodes a product which inhibits cell cycle progression. J. Virol. 70:3807-3814[Abstract]. |
| 23. |
Trousdale, M. D.,
I. Steiner,
J. G. Spivack,
S. L. Deshmane,
S. M. Brown,
A. R. MacLean,
J. H. Subak-Sharpe, and N. W. Fraser.
1991.
In vivo and in vitro reactivation impairment of a herpes simplex virus type 1 latency-associated transcript variant in a rabbit eye model.
J. Virol.
65:6989-6993 |
| 24. |
Wagner, E. K.,
G. Devi-Rao,
L. T. Feldman,
A. T. Dobson,
Y. F. Zhang,
W. M. Flanagan, and J. G. Stevens.
1988.
Physical characterization of the herpes simplex virus latency-associated transcript in neurons.
J. Virol.
62:1194-1202 |
| 25. |
Wechsler, S. L.,
A. B. Nesburn,
R. Watson,
S. M. Slanina, and H. Ghiasi.
1988.
Fine mapping of the latency-related gene of herpes simplex virus type 1: alternative splicing produces distinct latency-related RNAs containing open reading frames.
J. Virol.
62:4051-4058 |
| 26. |
Zwaagstra, J. C.,
H. Ghiasi,
S. M. Slanina,
A. B. Nesburn,
S. C. Wheatley,
K. Lillycrop,
J. Wood,
D. S. Latchman,
K. Patel, and S. L. Wechsler.
1990.
Activity of herpes simplex virus type 1 latency-associated transcript (LAT) promoter in neuron-derived cells. Evidence for neuron specificity and for a large LAT transcript.
J. Virol.
64:5019-5028 |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»